Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

Doctors should consider SLE in males even if antinuclear antibody tests are negative.

The document explains different hair loss types and treatments, emphasizing diagnosis through examination and tests, and specific treatments for each condition.

Platelet-rich plasma (PRP) may help treat hair loss in patients with frontal fibrosing alopecia who don't respond to other treatments.

Topical minoxidil is the primary treatment for female pattern hair loss in India.

Glucocorticoid treatment in lupus can cause oral lesions, which need early diagnosis and comprehensive care.

Panchkarma treatment can help manage symptoms of Systemic Lupus Erythematous.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

The document lists dermatology topics across life stages and notes hair loss can affect self-esteem and early skin cancer treatment is crucial.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Effective acne treatment varies by type, with topical and oral medications showing strong evidence, and patient education and support are crucial.

Physical inactivity is a primary cause of many human illnesses.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Methotrexate is effective and well-tolerated in children for certain skin conditions but requires careful monitoring.

Elastin staining helps assess late-stage scarring alopecia but is not definitive, and clinical diagnosis is still crucial.

Mitochondrial dysfunction is linked to various skin conditions and could be a target for treatments.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Primary cicatricial alopecia, a rare disorder causing permanent hair loss, is hard to diagnose and treat, with treatments like anti-inflammatory drugs and steroids offering varied results and no guaranteed cure. Psychological support for patients is important, and future research should aim to identify causes of the condition.

Systemic treatments like hydroxychloroquine and cyclosporine A help with Lichen Planopilaris and Frontal Fibrosing Alopecia, but ongoing treatment is needed.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Platelet-rich plasma injections can help treat hair loss in lupus patients.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Cicatricial alopecia involves scarring hair loss and can be treated with various medications.

Topical treatment is recommended for Folliculitis decalvans in pregnant women.